Pulmonary Embolism as Common in Children as Adults
A study of over 4,000 children found an unexpectedly high frequency of pulmonary embolism—equal to rates seen in adults.
Category: Pulmonary Embolism
Pulmonary Embolism
Latest
Pulmonary Embolism as Common in Children as Adults
A study of over 4,000 children found an unexpectedly high frequency of pulmonary embolism—equal to rates seen in adults.
Read More
SonoThrombectomy Ultrasound System Shows Promise as Embolism Therapy
SonoVascular Inc’s SonoThrombectomy System is a catheter-based system that delivers ultrasound energy, microbubbles and thrombolytic drug to break down blood clots via an integrated mechanical-pharmacological approach.
Read More
Future NBA Hall of Famer Sidelined by DVT
An NBA all-star for the Milwaukee Bucks will miss the remainder of the NBA regular season after being diagnosed with deep vein thrombosis (DVT).
Read More
Preventing and Recognizing Pediatric Emboli
Cardiorespiratory specialists warn discuss warning signs for pediatric emboli, which are on the rise, they say.
Read More
Air Pollution Tied to Venous Thromboembolism (VTE)
Greater exposure to long-term air pollution was linked with increased risks for venous thromboembolism — blood clots that can occur in deep veins.
Read More
NBA Star Victor Wembanyama Diagnosed with DVT
The San Antonio Spurs report center Victor Wembanyama has been diagnosed with deep vein thrombosis (DVT) in his shoulder and will miss the rest of the NBA’s regular season.
Read More
Trial Launches to Test Novel Device for Treating Pulmonary Embolism
Argon Medical Devices has enrolled the first patient in a US-based study exploring a novel catheter-based device for managing blood clots in the lungs.
Read More
Air Pollution Linked to Increased Risk of Venous Thromboembolism
The likelihood of VTE was linked to anywhere from a 39% to a more than two-fold increased risk based on long-term exposure to three different types of air pollutants.
Read More
FDA Clears AlphaVac F1885 System for Treatment of Pulmonary Embolism
The clearance broadens the applicability of the AlphaVac F1885 System in the non-surgical removal of thrombi or emboli from the venous vasculature.
Read More
Most Low-risk Pulmonary Embolism Patients Still Hospitalized After ED Visit
The trend of hospitalizing low-risk PE patients continues despite evidence supporting safe outpatient care, according to a new analysis.
Read More
Endovascular Catheter Opens Blocked Arteries Deep Within Lungs
New research shows an endovascular catheter, recently approved by the FDA and already shown to be effective in reducing blockages in lung arteries, also reduces blockages in the smaller segmental pulmonary artery branches.
Read More
Pulmonary Embolism Death Rates Defy Medical Advancements
Despite advancements, a Michigan Medicine study finds that the death rate for pulmonary embolism remains high and unchanged in recent years—more often killing men, Black patients, and those from rural areas.
Read More
Modern Blood Thinners Slash Bleeding Risk for Lung Blood Clot Treatment
Modern blood-thinning drugs (known as NOACs) reduce the risk of serious bleeding by up to 45% compared to the traditional drug warfarin in the treatment of blood clots in the lungs and legs, according to a new long-term study.
Read More
Bias May Affect Testing for Pulmonary Embolism
ED patients with congestive heart failure and dyspnea are less likely to be tested for pulmonary embolism when their ED forms specifically mention CHF instead of “shortness of breath.”
Read More
Indefinite Anticoagulation for VTE Lacks Mortality Benefits, Cost-effectiveness
A modeling study suggests that continuing anticoagulation therapy indefinitely, which is recommended in all patients with a first unprovoked venous thromboembolism, has little chance of improving life expectancy and is unlikely to ever be cost-effective.
Read More
CT Scans Potentially Over-hospitalizing Pulmonary Embolism Patients
A new study suggests CT results alone may not confer as much risk as traditionally thought—a finding that will come as a surprise to most emergency physicians, according to one of the study’s authors.
Read More
Short Sleep Tied to Increased Risk of Peripheral Artery Disease
Sleeping less than five hours a night is associated with a 74% raised likelihood of developing peripheral artery disease (PAD) compared with seven to eight hours of sleep.
Read More
Poor Sleep Tied to Greater Risk of Peripheral Artery Disease
Sleeping less than five hours a night is associated with a 74% greater likelihood of developing peripheral artery disease (PAD) compared with seven to eight hours of sleep, according to new research.
Read More
Peripheral Artery Disease Underdiagnosed, Undertreated in Women
Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in women, according new research that highlights the biological, clinical and societal reasons why the condition may be missed in women, who respond less well to treatment and have worse clinical outcomes.
Read More
FDA Clearance for Rapid RV/LV Pulmonary Embolism Care Solution
Rapid RV/LV is designed to help physicians quickly assess the severity of a suspected pulmonary embolism.
Read More
Greater VTE Risk for Obese Women Using Combo Birth Control Pill
Obese women who use oral contraceptives containing estrogen and progestin have a 24-fold increased risk of venous thromboembolism (VTE) compared with non-obese women not using the drugs, according to a review paper published in ESC Heart Failure.
Read More
Obstructive Sleep Apnea Linked to Increased Risk of Cancer, Reduced Cognitive Function, Increased Risk of Blood Clots
People who suffer from obstructive sleep apnea are at an increased risk of cancer and emboli, and a decline in cognitive functions.
Read More
Full-dose Anticoagulation Lowers Embolism Risk in COVID-19 Patients
Treatment of critically ill COVID-19 patients with full-dose anticoagulation lowers the risk of venous and arterial clotting complications by 44% compared with the standard dose, according to research presented at ESC Congress 2022.
Read More
‘Rogue Antibodies’ Involved in Severe COVID-19 Blood Clots
Circulating antiphospholipid antibodies which target a person’s own organs and systems, can also be activated in response to viral infections and may play a role with COVID-19 blood clots.
Read More